Sandeep N. Shah, Ph.D. - Publications

Affiliations: 
2010 Genetics Pennsylvania State University, State College, PA, United States 
Area:
Genetics, Molecular Biology, Biochemistry

13 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 All AH, Gharibani P, Gupta S, Bazley FA, Pashai N, Chou BK, Shah S, Resar LM, Cheng L, Gearhart JD, Kerr CL. Early intervention for spinal cord injury with human induced pluripotent stem cells oligodendrocyte progenitors. Plos One. 10: e0116933. PMID 25635918 DOI: 10.1371/Journal.Pone.0116933  0.304
2014 Hillion J, Belton AM, Shah SN, Turkson J, Jing N, Tweardy DJ, di Cello F, Huso DL, Resar LM. Nanoparticle delivery of inhibitory signal transducer and activator of transcription 3 G-quartet oligonucleotides blocks tumor growth in HMGA1 transgenic model of T-cell leukemia. Leukemia & Lymphoma. 55: 1194-7. PMID 23829279 DOI: 10.3109/10428194.2013.821202  0.383
2013 Shah SN, Cope L, Poh W, Belton A, Roy S, Talbot CC, Sukumar S, Huso DL, Resar LMS. HMGA1: A Master Regulator of Tumor Progression in Triple-Negative Breast Cancer Cells Plos One. 8. PMID 23658826 DOI: 10.1371/Journal.Pone.0063419  0.355
2013 Shah SN, Cope L, Belton A, Poh W, Sukumar S, Huso D, Resar L. Abstract 3122: HMGA1 reprograms breast cancer cells by inducing transcriptional networks involved in an epithelial-mesenchymal transition, stemness, and metastatic progression. Cancer Research. 73: 3122-3122. DOI: 10.1158/1538-7445.Am2013-3122  0.362
2012 Shah SN, Kerr C, Cope L, Zambidis E, Liu C, Hillion J, Belton A, Huso DL, Resar LM. HMGA1 reprograms somatic cells into pluripotent stem cells by inducing stem cell transcriptional networks. Plos One. 7: e48533. PMID 23166588 DOI: 10.1371/Journal.Pone.0048533  0.346
2012 Shah SN, Resar LM. High mobility group A1 and cancer: potential biomarker and therapeutic target. Histology and Histopathology. 27: 567-79. PMID 22419021 DOI: 10.14670/Hh-27.567  0.434
2012 Resar L, Shah SN, Kerr C, Cope L, Zambidis E, Belton A, Huso DL. HMGA1, a Factor Enriched in Hematopoietic Stem Cells, Embryonic Stem Cells, and Hematologic Malignancy, Enhances Cellular Reprogramming to a Pluripotent Stem-Like Cell. Blood. 120: 2323-2323. DOI: 10.1182/Blood.V120.21.2323.2323  0.372
2012 Shah SN, Kerr C, Cope L, Mali P, Zambidis E, Lui C, Hillion J, Belton A, Huso D, Resar L. Abstract 429: The high mobility group A1 oncogene enhances cellular reprogramming to a pluripotent stem-like cell Cancer Research. 72: 429-429. DOI: 10.1158/1538-7445.Am2012-429  0.384
2011 Schuldenfrei A, Belton A, Kowalski J, Talbot CC, Di Cello F, Poh W, Tsai HL, Shah SN, Huso TH, Huso DL, Resar LMS. HMGA1 drives stem cell, inflammatory pathway, and cell cycle progression genes during lymphoid tumorigenesis Bmc Genomics. 12. PMID 22053823 DOI: 10.1186/1471-2164-12-549  0.362
2011 Schuldenfrei A, Belton A, Kowalski J, Talbot CC, Cello FD, Poh W, Tsai H, Shah SN, Huso T, Huso D, Resar L. HMGA1 Drives Inflammatory Pathways, Cell Cycle Progression, and Embryonic Stem Cell Genes During Leukemic Transformation Blood. 118: 1371-1371. DOI: 10.1182/Blood.V118.21.1371.1371  0.333
2010 Shah SN, Hile SE, Eckert KA. Defective mismatch repair, microsatellite mutation bias, and variability in clinical cancer phenotypes. Cancer Research. 70: 431-5. PMID 20068152 DOI: 10.1158/0008-5472.Can-09-3049  0.57
2010 Shah SN, Opresko PL, Meng X, Lee MY, Eckert KA. DNA structure and the Werner protein modulate human DNA polymerase delta-dependent replication dynamics within the common fragile site FRA16D. Nucleic Acids Research. 38: 1149-62. PMID 19969545 DOI: 10.1093/Nar/Gkp1131  0.569
2009 Shah SN, Eckert KA. Human postmeiotic segregation 2 exhibits biased repair at tetranucleotide microsatellite sequences. Cancer Research. 69: 1143-9. PMID 19155293 DOI: 10.1158/0008-5472.Can-08-3499  0.577
Show low-probability matches.